Sobi to present new gout data at ACR Convergence 2026

الملخص

STOCKHOLM, Nov. 3, 2026 — Sobi® (STO: SOBI) today announced that six abstracts covering pozdeutinurad (AR882), nanoencapsulated sirolimus plus pegadricase (NASP) and uncontrolled gout will be presented…